Lam Research Corporation $LRCX Shares Sold by DAVENPORT & Co LLC

DAVENPORT & Co LLC reduced its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 20.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,441 shares of the semiconductor company’s stock after selling 5,248 shares during the period. DAVENPORT & Co LLC’s holdings in Lam Research were worth $3,499,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. PMV Capital Advisers LLC acquired a new position in Lam Research in the 4th quarter valued at about $25,000. Stance Capital LLC acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $26,000. Triumph Capital Management acquired a new stake in shares of Lam Research during the 3rd quarter worth approximately $27,000. Harbor Investment Advisory LLC raised its position in shares of Lam Research by 73.9% during the 4th quarter. Harbor Investment Advisory LLC now owns 240 shares of the semiconductor company’s stock valued at $41,000 after buying an additional 102 shares during the period. Finally, Howard Hughes Medical Institute purchased a new stake in shares of Lam Research during the 2nd quarter valued at approximately $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Price Performance

Shares of LRCX opened at $211.41 on Friday. The company has a market cap of $264.00 billion, a P/E ratio of 43.32, a PEG ratio of 2.28 and a beta of 1.77. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $256.68. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37. The firm’s 50 day moving average price is $227.81 and its 200 day moving average price is $181.35.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the firm posted $0.91 earnings per share. The company’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is presently 21.31%.

Insiders Place Their Bets

In other Lam Research news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares in the company, valued at $57,235,848. This represents a 12.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares in the company, valued at $242,334,371.15. This represents a 4.42% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 130,886 shares of company stock worth $29,658,802 in the last quarter. 0.31% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Royal Bank Of Canada reiterated an “outperform” rating and issued a $290.00 price objective (up from $260.00) on shares of Lam Research in a research report on Thursday, January 29th. Argus lifted their target price on Lam Research from $175.00 to $280.00 in a research report on Tuesday, February 3rd. Evercore set a $275.00 price target on Lam Research in a research note on Thursday, January 29th. The Goldman Sachs Group set a $262.00 price target on Lam Research and gave the stock a “buy” rating in a report on Thursday, January 29th. Finally, Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $245.35.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.